←
BHPG831 posts
BHPG avatar

BHPG

@heppharm

British Hepatology Pharmacy Group. Affiliate group of BASL for pharmacists and pharmacy technicians aiming to develop knowledge/understanding of liver disorders

◷ Joined September 2018▧ 231 Photos and videos
Elliot Tapper avatar
⟳ BHPG retweeted
Elliot Tapper@ebtapper·Mar 22

Naltrexone should be first line for AUD in people with cirrhosis It is increasingly uncomfortable to see baclofen mentioned alongside it, or even acamprosate

Post attachment
NEJM avatar
⟳ BHPG retweeted
NEJM@NEJM·29 Oct 2025

The prognosis of liver disease depends on the extent of fibrosis, which is usually staged with the use of liver biopsy. The limitations of biopsy have led to the development of noninvasive tests, which Drs. Laurent Castera, Mary E. Rinella, and Emmanuel A. Tsochatzis review. Learn more: nej.md/4hwZMgj

Post attachment
Frontline Gastro avatar
⟳ BHPG retweeted
Frontline Gastro@FrontGastro_BMJ·11 Oct 2025

🟢 10/14 | BASL × FG Special Issue “Personalised treatment is reshaping how we manage difficult autoimmune hepatitis.” 🧬 Optimised thiopurine therapy + metabolite monitoring now standard of care 💊 MMF established as leading 2nd-line — and viable 1st-line in select cases 🧪 Tacrolimus, infliximab & rituximab emerging for refractory disease 📰 Read the full review ➡️ fg.bmj.com/content/16/e1/e77 #AutoimmuneHepatitis #Hepatology #FGBASLSpecialIssue @basl_events @heppharm @livernursing @LiverAHPs @Liver4Lifeuk @f4liverresearch @IQILS_Liver @LiverTrust @EASLedu @EASLnews @BritSocGastro @BavenoCoop @BCLC_group @ILCAnews @APASLnews @liverfellow @my_ueg @UKCPAGastro @PhilSmithIsBack @OTavabie @dr_aditi_kumar @TrevorTabone @eathar_s @IrenePerezMD @KGananandan @zare_benjamin @medicalreg @dtleiberman @BSGtrainees @drkeithsiau @ebtapper @DrLChina @acv69cardenas @GeriKeane @jamesbmaurice @ClinicLiver

Post attachmentPost attachment
BHPG avatar
BHPG@heppharm·10 Oct 2025

🔔 Useful tools and information for all pharmacists helping to write and implement clinical guidelines for #hepatology in 🇬🇧

EASLnews@EASLnews10 Oct 2025

📢 NEW! EASL’s new Guidelines Dissemination Programme advances liver care by promoting awareness and uptake of Clinical Practice Guidelines. Its key initiative, the EASL Guidelines Implementation Programme, turns recommendations into practical tools for everyday use. Discover the first edition focused on the EASL–EASD–EASO CPGs for #MASLD: EASL MASLD Guidelines Implementation Programme: easlcampus.eu/easl-guideline… #LiverTwitter #LiverX @DebbieShawcros1 @analleo @FrancqueSven @MajaThiele

Post attachment
BHPG avatar
BHPG@heppharm·9 Oct 2025

Always lovely to hear great engagement and response from our efforts! ✨ @Yun_Pharmacist definitely outdid herself on summarising the use of GLP1RA and the future of MASLD therapy for all of us.

Post attachmentPost attachmentPost attachment

GLP-1 agonists: Benefits and challenges. One of the hottest topics at the moment in light of MASLD/MASH (shown by the amount of ppl who left after the talk to go back to the medics meeting!!). Thank you @Yun_Pharmacist for a great informative talk @heppharm @livernursing @BASLedu

Post attachmentPost attachment
BHPG avatar
BHPG@heppharm·9 Oct 2025

Posters @ #BASL2025: Hannah Hesketh presents data on terlipressin use in HRS-1 post MHRA alert. We are currently collecting more 🇬🇧 data on this topic, please contact leslie.wong1@nhs.net for more information. @geshNHS #research

Post attachmentPost attachment